Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Milestone Pharmaceuticals Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +1 vs. Q4 2021
- Shares held
- 21.0M
- +804.5K (+4.0%) vs. Q4 2021
- Total value
- $135.1M
- +$2.53M (+1.9%) vs. Q4 2021
- New holders
- 4
- 12 more added
- Sold out
- 3
- 3 more reduced
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 2,879 | $18.0K | 0.00% | +359+14.2% | Added |
| BNP Paribas Arbitrage, SA | 3,848 | $24.7K | 0.00% | +3,848 | New |
| PDT Partners, LLC | 10,165 | $65.0K | 0.01% | +10,165 | New |
| Federation des caisses Desjardins du Quebec | 10,500 | $67.4K | 0.00% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 12,004 | $77.0K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 13,580 | $87.0K | 0.00% | +6,606+94.7% | Added |
| National Bank of Canada | 14,842 | $94.0K | 0.00% | +100+0.7% | Added |
| Geode Capital Management, LLC | 17,576 | $112.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 19,270 | $122.0K | 0.00% | +6,889+55.6% | Added |
| State Street Corp | 21,802 | $140.0K | 0.00% | +970+4.7% | Added |
| Susquehanna Fundamental Investments, LLC | 23,854 | $153.0K | 0.00% | −7,988−25.1% | Reduced |
| Royal Bank of Canada | 26,502 | $170.0K | 0.00% | +499+1.9% | Added |
| Dimensional Fund Advisors LP | 61,743 | $397.0K | 0.00% | +9,165+17.4% | Added |
| Eversept Partners, LP | 147,165 | $944.8K | 0.09% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 184,198 | $1.18M | 0.04% | +9,735+5.6% | Added |
| Barclays PLC | 226,710 | $1.46M | 0.00% | +23,697+11.7% | Added |
| Bleichroeder LP | 250,000 | $1.60M | 0.28% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 380,000 | $2.44M | 1.16% | +380,000 | New |
| Lion Point Capital, LP | 683,570 | $4.39M | 1.48% | +683,570 | New |
| Morgan Stanley | 818,640 | $5.26M | 0.00% | −7,356−0.9% | Reduced |
| Pura Vida Investments, LLC | 987,411 | $6.34M | 0.77% | +55,900+6.0% | Added |
| Millennium Management LLC | 1,288,923 | $8.28M | 0.01% | +303,056+30.7% | Added |
| Ikarian Capital, LLC | 1,928,752 | $12.4M | 3.77% | +178,709+10.2% | Added |
| Boxer Capital, LLC | 2,238,861 | $14.4M | 0.74% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 2,246,503 | $14.4M | 0.31% | 00.0% | Unchanged |
| Novo Holdings A/S | 2,530,003 | $16.2M | 0.86% | −5820.0% | Reduced |
| OrbiMed Advisors LLC | 2,583,821 | $16.6M | 0.27% | 00.0% | Unchanged |
| RTW Investments, LP | 4,315,102 | $27.7M | 0.57% | 00.0% | Unchanged |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −851,291−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,031−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −555−100.0% | Sold out |
| Carroll Financial Associates, Inc. | – | – | – | – | Not filed |